Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics

References

1. 1.↵
   Centers for Disease Control and Prevention. Most Recent Asthma Data. http://www.cdc.gov/asthma/most_recent_data.htm. Accessed April 25, 2017.
2. 2.↵
   National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Aug 2007. NIH publication no. 07-4051. http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed December 30, 2015.
3. 3.↵
   1. Dolovich MB,
   2. Ahrens RC,
   3. Hess DR,
   4. Anderson P,
   5. Dhand R,
   6. Rau JL,
   7. et al

   . Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335–371.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   VentolinR HFA package insert. Highlights of prescribing information. Philadelphia, Pennsylvania: GlaxoSmithKline; June 2009.
5. 5.
   ProAirR HFA package insert. Highlights of prescribing information. Horsham, Pennsylvania: Teva Respiratory; Revised July 2010.
6. 6.↵
   ProventilR HFA package insert. Prescribing information. Kenilworth, New Jersey: Schering-Plough Corporation; Revised November 2010.
7. 7.↵
   1. Hautmann J,
   2. Godoy SE,
   3. Marshik P,
   4. Chand R,
   5. McConville J,
   6. Krishna S,
   7. et al

   . Effect of time between actuation on the dose variability for three metered dose inhalers. Respir Drug Deliv Eur 2013;2:429–434.

   OpenUrl
8. 8.↵
   1. Clark DJ,
   2. Lipworth BJ

   . Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996;51(10):981–984.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. McCabe JC,
   2. Koppenhagen F,
   3. Blair J,
   4. Zeng XM

   . ProAir HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin HFA. J Aerosol Med and Pulm Drug Deliv 2012;25(2):104–109.

   OpenUrl
10. 10.↵
    1. Marple VA,
    2. Olson BA,
    3. Santhanakrishnan K,
    4. Mitchell JP,
    5. Murray SC,
    6. Hudson-Curtis BL

    . Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration. J Aerosol Med 2003;16(3):301–324.

    OpenUrlPubMed
11. 11.↵
    1. Kelly HW,
    2. Ahrens RC,
    3. Holmes M,
    4. Stevens AL,
    5. Vandermeer AK,
    6. Garris T,
    7. Reisner C

    . Evaluation of particle size distribution of salmeterol administered via metered-dose inhaler with and without valved holding chambers. Ann Allergy Asthma Immunol 2001;87(6):482–487.

    OpenUrlPubMed
12. 12.↵
    1. Slator L,
    2. von Hollen D,
    3. Sandell D,
    4. Hatley RH

    . In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers. J Aerosol Med Pulm Drug Deliv 2014;27 Suppl 1:S37–S43.

    OpenUrlPubMed
13. 13.↵
    1. Rau JL,
    2. Coppolo DP,
    3. Nagel MW,
    4. Avvakoumova VI,
    5. Doyle CC,
    6. Wiersema KJ,
    7. Mitchell JP

    . The importance of nonelectrostatic materials in holding chambers for delivery of hydrofluoroalkane albuterol. Respir Care 2006;51(5):503–510.

    OpenUrlAbstract/FREE Full Text